Claims
- 1. The compound of Formula (I), 8-[4-[4-(5-fluoro-2-pyrimidinyl)-1-piperazine]butyl]-8-azaspiro[4.5]decane-7,9-dione, and pharmaceutically acceptable acid addition salts thereof ##STR16##
- 2. The process for eliciting an antipsychotic effect in a psychotic mammal which comprises administration to said mammal of a non-toxic but effective antipsychotic dose of the compound of Formula (I) of claim 1 or a pharmaceutically acceptable acid addition salt thereof.
- 3. A pharmaceutical composition in dosage unit form suitable for systemic administration to a mammalian host comprising a pharmaceutical carrier and a compound of Formula (I) of claim 1 or a pharmaceutically acceptable acid addition salt thereof.
CROSS-REFERENCE TO RELATED APPLICATION
This is a continuation-in-part of co-pending application U.S. Ser. No. 464,275 filed Feb. 7, 1983, now abandoned.
US Referenced Citations (6)
Non-Patent Literature Citations (2)
Entry |
Y. H. Wu, et al., J. Med. Chem., 15/5, 477-479 (1972). |
Y. H. Wu, et al., Journal Medicinal Chemistry, 12/4, 876-881 (1969). |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
464275 |
Feb 1983 |
|